Logo
x

Search category

Subscribe Now

Exclusive Commercialization Agreement

Alvotech and Alvotech & CCHT Sign an Exclusive Commercialization Agreement with Yangtze River for Eight Biosimilars in China

Alvotech and Alvotech & CCHT Sign an Exclusive Commercialization Agreement with Yangtze River for Eight Biosimilars in China

  • November 25, 2020
Lotus Signs an Exclusive Commercialization Agreement with CKD for Biosimilar Darbepoetin Alfa

Lotus Signs an Exclusive Commercialization Agreement with CKD for Biosimilar Darbepoetin Alfa

  • September 18, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.